Technical Analysis for OPGN - OpGen, Inc.

Grade Last Price % Change Price Change
D 2.32 -8.30% -0.21
OPGN closed down 8.3 percent on Thursday, April 15, 2021, on 11 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.
Earnings due: May 5
*** please verify all earnings dates ***

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Down
Historical OPGN trend table...

Date Alert Name Type % Chg
Below Lower BB Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
180 Bearish Setup Bearish Swing Setup -8.30%
Stochastic Reached Oversold Weakness -8.30%
Oversold Stochastic Weakness -8.30%
Narrow Range Bar Range Contraction -9.38%
Fell Below 50 DMA Bearish -9.38%
MACD Bearish Centerline Cross Bearish -9.38%
50 DMA Support Bullish -13.11%
Older End-of-Day Signals for OPGN ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Fell Below Lower Bollinger Band about 16 hours ago
Down 5% about 18 hours ago
Lower Bollinger Band Support about 18 hours ago
Down 3% about 19 hours ago
Down 2 % about 19 hours ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

OpGen, Inc. Description

OpGen, Inc. operates as an early commercial stage company using molecular testing and bioinformatics to assist healthcare providers to combat multi-drug-resistant bacterial infections. It offers Acuitas multi-drug-resistant organisms (MDRO) gene test, a molecular screening tool that detects 10 critical MDRO genes from 1 patient swab. The company also provides Acuitas CR Elite Test, which adds the ability to procure a standard microbiological culture result that provides additional information about the identified MDRO gene and its antibiotic susceptibility profile. In addition, it develops Acuitas Lighthouse MDRO bioinformatics product, which focuses on providing MDRO molecular information about an individual patient's resistance profile. OpGen, Inc. has a strategic collaboration with Hitachi High-Technologies Corporation to commercialize its genome mapping technology for mapping, assembly, and analysis of human DNA. The company was incorporated in 2001 and is headquartered in Gaithersburg, Maryland.


Classification

Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Healthcare Providers Antibiotic Informatics Bacterial Infections Genome Organisms Bioinformatics Elite Veterinary Medicine Bacteria Antimicrobial Resistance Evolutionary Biology Hitachi Multi Drug Resistant Bacterial Infections

Is OPGN a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 4.44
52 Week Low 1.63
Average Volume 13,608,822
200-Day Moving Average 2.29
50-Day Moving Average 2.69
20-Day Moving Average 2.69
10-Day Moving Average 2.61
Average True Range 0.24
ADX 24.16
+DI 22.36
-DI 22.64
Chandelier Exit (Long, 3 ATRs ) 2.47
Chandelier Exit (Short, 3 ATRs ) 3.03
Upper Bollinger Band 3.03
Lower Bollinger Band 2.34
Percent B (%b) -0.03
BandWidth 25.74
MACD Line -0.05
MACD Signal Line -0.01
MACD Histogram -0.0405
Fundamentals Value
Market Cap 52.17 Million
Num Shares 22.5 Million
EPS -26.10
Price-to-Earnings (P/E) Ratio -0.09
Price-to-Sales 6.19
Price-to-Book 2.59
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.74
Resistance 3 (R3) 2.79 2.69 2.67
Resistance 2 (R2) 2.69 2.59 2.67 2.65
Resistance 1 (R1) 2.51 2.52 2.46 2.46 2.62
Pivot Point 2.41 2.41 2.39 2.39 2.41
Support 1 (S1) 2.23 2.31 2.18 2.18 2.02
Support 2 (S2) 2.13 2.24 2.11 1.99
Support 3 (S3) 1.95 2.13 1.97
Support 4 (S4) 1.90